RAPAMUNE Side Effects

7013391-2 |
on Sep 20, 2010 Male patient from COLOMBIA , child 11 years of age, was diagnosed with renal transplant and was treated with Rapamune (View Usage). . Rapamune dosage: .

7011288-5 | Depression, Irritability, Libido Decreased, Listless
Patient was taking Rapamune (View Usage). Patient had the following side effects: depression (What is depression?), irritability, libido decreased, listless on Dec 16, 2008 from UNITED STATES Additional patient health information: Male patient , 73 years of age, was diagnosed with prophylaxis against transplant rejection and. Rapamune dosage: . During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), ARAVA (View Arava Review and Arava Label ), PRAVACHOL (View Pravachol Review and Pravachol Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), CENTRUM SILVER (View Centrum Silver Review and Centrum Silver Label ), ZANTAC (View Zantac Review and Zantac Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ).

7011058-8 | Acute Respiratory Distress Syndrome, Alveolitis, Bacteraemia, Interstitial Lung Disease, Lung Infection Pseudomonal, Renal Impairment, Respiratory Failure, Sepsis, Urinary Tract Infection
Adverse event was reported on Nov 06, 2008 by a Female patient taking Rapamune (View Usage) (Dosage: ) was diagnosed with prophylaxis against transplant rejection, candidiasis, atrial fibrillation (What is atrial fibrillation?), antifungal prophylaxis and. Location: UNITED STATES , weighting 127.9 lb, After Rapamune was administered, patient had the following side effects: acute respiratory distress syndrome, alveolitis, bacteraemia, interstitial lung disease, lung infection pseudomonal, renal impairment, respiratory failure, sepsis (What is sepsis?), urinary tract infection (What is urinary tract infection?). During the same period patient was treated with NYSTATIN (View Nystatin Review and Nystatin Label ), FLAGYL (View Flagyl Review and Flagyl Label ), CARDIZEM (View Cardizem Review and Cardizem Label ), MEPRON (View Mepron Review and Mepron Label ). Patient was hospitalized.

7002426-9 | Colitis Ischaemic
on Sep 14, 2010 Female patient from PHILIPPINES , 43 years of age, was treated with Rapamune (View Usage). Patient experienced the following unwanted or unexpected effects: colitis ischaemic. Rapamune dosage: Dose And Frequency Not Specified.


6988392-0 | Prostate Cancer
on Sep 08, 2010 Male patient from GERMANY , weighting 172.0 lb, was diagnosed with prophylaxis against transplant rejection, prophylaxis against gastrointestinal ulcer, osteoporosis prophylaxis, lipids increased and was treated with Rapamune (View Usage). Patient had the following side effects: prostate cancer (What is prostate cancer?). Rapamune dosage: . During the same period patient was treated with PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), IDEOS (1 Chewing Tablet Per Day) (View Ideos Review and Ideos Label ), ADVAGRAF (View Advagraf Review and Advagraf Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ).

6962679-X | Confusional State, Disorientation, False Positive Investigation Result, Infection
Patient was taking Rapamune (View Usage). After Rapamune was administered, patient had the following side effects: confusional state, disorientation, false positive investigation result, infection (What is infection?) on Aug 25, 2010 from UNITED STATES Additional patient health information: Female patient , 71 years of age, was diagnosed with prophylaxis against transplant rejection and. Rapamune dosage: . Patient was hospitalized.

6933747-3 | Coagulopathy
Adverse event was reported on Aug 10, 2010 by a Female patient taking Rapamune (View Usage) (Dosage: ) . Location: TURKEY , weighting 198.4 lb, Patient experienced the following unwanted or unexpected effects: coagulopathy. During the same period patient was treated with MYFORTIC (View Myfortic Review and Myfortic Label ), PROGRAF (View Prograf Review and Prograf Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

6920022-6 | Chest Discomfort, Dyspnoea
on Aug 04, 2010 Female patient from UNITED KINGDOM , 55 years of age, was treated with Rapamune (View Usage). Patient had the following side effects: chest discomfort, dyspnoea. Rapamune dosage: .

6916706-6 | Dyspnoea, Lymphoedema
on Aug 09, 2010 Male patient from FRANCE , weighting 158.7 lb, was diagnosed with skin cancer (What is skin cancer?) and was treated with Rapamune (View Usage). After Rapamune was administered, patient had the following side effects: dyspnoea, lymphoedema. Rapamune dosage: 1 Mg Total Daily. During the same period patient was treated with PLAVIX (75 Mg Total Daily) (View Plavix Review and Plavix Label ), ATENOLOL (25 Mg Total Daily) (View Atenolol Review and Atenolol Label ), TAHOR (40 Mg Total Daily) (View Tahor Review and Tahor Label ), CELLCEPT (1500 Mg Total Daily) (View Cellcept Review and Cellcept Label ), RAMIPRIL (2.5 Mg) (View Ramipril Review and Ramipril Label ).

6882658-0 | Lung Disorder, Pneumonitis, Pulmonary Embolism, Weight Decreased
Patient was taking Rapamune (View Usage). Patient experienced the following unwanted or unexpected effects: lung disorder, pneumonitis, pulmonary embolism (What is pulmonary embolism?), weight decreased on Jul 19, 2010 from UNITED KINGDOM Additional patient health information: Female patient , weighting 148.4 lb, . Rapamune dosage: . During the same period patient was treated with ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), PENICILLIN NOS (View Penicillin Nos Review and Penicillin Nos Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), EZETIMIBE (View Ezetimibe Review and Ezetimibe Label ). Patient was hospitalized.

6882143-6 | Cough, Dyspnoea, Pneumonitis, Respiratory Disorder
Adverse event was reported on Jul 22, 2010 by a Male patient taking Rapamune (View Usage) (Dosage: ) was diagnosed with kidney transplant rejection and. Location: UNITED KINGDOM , weighting 217.4 lb, Patient had the following side effects: cough, dyspnoea, pneumonitis, respiratory disorder. During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), FRUSEMIDE (View Frusemide Review and Frusemide Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), SOTALOL HCL (View Sotalol Hcl Review and Sotalol Hcl Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), ALFACALCIDOL (0.25 Mcg, Daily) (View Alfacalcidol Review and Alfacalcidol Label ). Patient was hospitalized and became disabled.

6866472-8 | Cough, Dyspnoea, Pneumonitis
on Jul 19, 2010 Male patient from UNITED KINGDOM , weighting 217.4 lb, was diagnosed with kidney transplant rejection and was treated with Rapamune (View Usage). After Rapamune was administered, patient had the following side effects: cough, dyspnoea, pneumonitis. Rapamune dosage: . During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ALFACALCIDOL (0.25 Mcg, Daily) (View Alfacalcidol Review and Alfacalcidol Label ), SOTALOL (View Sotalol Review and Sotalol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), FRUSEMIDE (View Frusemide Review and Frusemide Label ). Patient was hospitalized and became disabled.

6863309-8 | Disease Progression, Therapeutic Response Unexpected, Tuberous Sclerosis
on Jul 13, 2010 Female patient from UNITED STATES , weighting 138.1 lb, was diagnosed with tuberous sclerosis (What is tuberous sclerosis?), angiomyolipoma, astrocytoma and was treated with Rapamune (View Usage). Patient experienced the following unwanted or unexpected effects: disease progression, therapeutic response unexpected, tuberous sclerosis (What is tuberous sclerosis?). Rapamune dosage: . During the same period patient was treated with CARBATROL (View Carbatrol Review and Carbatrol Label ), FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ), IBUPROFEN (Dose Not Provided, Taken As Needed) (View Ibuprofen Review and Ibuprofen Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), LORATADINE (View Loratadine Review and Loratadine Label ), ACETAMINOPHEN (Dose Not Provided, Taken As Needed) (View Acetaminophen Review and Acetaminophen Label ).

6836307-8 | Dyspnoea, Lymphoedema
Patient was taking Rapamune (View Usage). Patient had the following side effects: dyspnoea, lymphoedema on Jul 12, 2010 from FRANCE Additional patient health information: Male patient , 72 years of age, was diagnosed with prophylaxis against transplant rejection and. Rapamune dosage: .

6827266-2 | Palpitations, Tachycardia
Adverse event was reported on Jul 07, 2010 by a Male patient taking Rapamune (View Usage) (Dosage: ) was diagnosed with renal transplant and. Location: SWITZERLAND , 75 years of age, After Rapamune was administered, patient had the following side effects: palpitations, tachycardia. Patient was hospitalized.

6827238-8 | Dyspnoea, Lymphoedema
on Jul 06, 2010 Male patient from FRANCE , 72 years of age, was diagnosed with prophylaxis against transplant rejection and was treated with Rapamune (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, lymphoedema. Rapamune dosage: .

6809504-5 | Bone Pain, Proteinuria
on Jun 22, 2010 Male patient from UNITED STATES , weighting 200.2 lb, was diagnosed with prophylaxis against transplant rejection and was treated with Rapamune (View Usage). Patient had the following side effects: bone pain, proteinuria. Rapamune dosage: .

6790817-0 | Condition Aggravated, Hydronephrosis, Pain, Renal Failure Chronic, Tubulointerstitial Nephritis
Patient was taking Rapamune (View Usage). After Rapamune was administered, patient had the following side effects: condition aggravated, hydronephrosis, pain (What is pain?), renal failure chronic, tubulointerstitial nephritis on Jun 18, 2010 from SWITZERLAND Additional patient health information: Male patient , 68 years of age, was diagnosed with pain (What is pain?) and. Rapamune dosage: . During the same period patient was treated with NITRODERM (View Nitroderm Review and Nitroderm Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), NEXIUM (View Nexium Review and Nexium Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), CERTICAN (View Certican Review and Certican Label ), NOZINAN (View Nozinan Review and Nozinan Label ), NOVALGIN (View Novalgin Review and Novalgin Label ), MAPROTILINE MESILATE (View Maprotiline Mesilate Review and Maprotiline Mesilate Label ). Patient was hospitalized.

6782986-3 | Hepatic Fibrosis
Adverse event was reported on Jun 15, 2010 by a Male patient taking Rapamune (View Usage) (Dosage: ) was diagnosed with prophylaxis against transplant rejection and. Location: GERMANY , weighting 145.5 lb, Patient experienced the following unwanted or unexpected effects: hepatic fibrosis. During the same period patient was treated with PREDNISOLONE (2.5 Mg/frequency Not Provided) (View Prednisolone Review and Prednisolone Label ), CLEXANE (Not Provided) (View Clexane Review and Clexane Label ), PANTOZOL (40 Mg/frequency Not Provided) (View Pantozol Review and Pantozol Label ), RAMIPRIL (2.5 Mg/frequency Not Provided) (View Ramipril Review and Ramipril Label ), CELLCEPT (2 Times 500 Mg/frequency Not Provided) (View Cellcept Review and Cellcept Label ), URSO FALK (2 Times 500 Mg/frequency Not Provided) (View Urso Falk Review and Urso Falk Label ). Patient was hospitalized.

6775290-0 | Hospitalisation
on Jun 15, 2010 Female patient from UNITED STATES , weighting 52.50 lb, was diagnosed with neurofibromatosis (What is neurofibromatosis?) and was treated with Rapamune (View Usage). Patient had the following side effects: hospitalisation. Rapamune dosage: 1.1 Ml Bid Po. During the same period patient was treated with AEOROLSOLIZED PENTAMIDINE (View Aeorolsolized Pentamidine Review and Aeorolsolized Pentamidine Label ). Patient was hospitalized.

6768705-5 | Amyotrophy, Bone Pain, Polyneuropathy, Quadriplegia
on Jun 11, 2010 Male patient from GERMANY , 56 years of age, weighting 145.5 lb, was diagnosed with renal transplant and was treated with Rapamune (View Usage). After Rapamune was administered, patient had the following side effects: amyotrophy, bone pain, polyneuropathy, quadriplegia. Rapamune dosage: .

6768658-X | Gastroenteritis, Pyelonephritis
Patient was taking Rapamune (View Usage). Patient experienced the following unwanted or unexpected effects: gastroenteritis (What is gastroenteritis?), pyelonephritis on Jun 04, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 220.2 lb, was diagnosed with prophylaxis against transplant rejection, neuropathy peripheral, hypothyroidism, sinus congestion, hypertension, proteinuria and. Rapamune dosage: . During the same period patient was treated with NEURONTIN (View Neurontin Review and Neurontin Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), LORATADINE (View Loratadine Review and Loratadine Label ), COREG (View Coreg Review and Coreg Label ), LASIX (View Lasix Review and Lasix Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ). Patient was hospitalized.

6768060-0 | Hepatic Fibrosis
Adverse event was reported on Jun 11, 2010 by a Male patient taking Rapamune (View Usage) (Dosage: ) was diagnosed with prophylaxis against transplant rejection and. Location: GERMANY , weighting 145.5 lb, Patient had the following side effects: hepatic fibrosis. During the same period patient was treated with PREDNISOLONE (2.5 Mg/frequency Not Provided) (View Prednisolone Review and Prednisolone Label ), CLEXANE (Not Provided) (View Clexane Review and Clexane Label ), PANTOZOL (40 Mg/frequency Not Provided) (View Pantozol Review and Pantozol Label ), RAMIPRIL (2.5 Mg/frequency Not Provided) (View Ramipril Review and Ramipril Label ), CELLCEPT (2 Times 500 Mg/frequency Not Provided) (View Cellcept Review and Cellcept Label ), URSO FALK (2 Times 500 Mg/frequency Not Provided) (View Urso Falk Review and Urso Falk Label ). Patient was hospitalized.

6758201-3 | Pulmonary Toxicity
on Jun 01, 2010 Female patient from BRAZIL , 27 years of age, was diagnosed with prophylaxis against transplant rejection and was treated with Rapamune (View Usage). After Rapamune was administered, patient had the following side effects: pulmonary toxicity. Rapamune dosage: Not Provided. During the same period patient was treated with MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ). Patient was hospitalized.

6754643-0 | Tubulointerstitial Nephritis
on May 25, 2010 Female patient from AUSTRIA , 55 years of age, was diagnosed with immunosuppression and was treated with Rapamune (View Usage). Patient experienced the following unwanted or unexpected effects: tubulointerstitial nephritis. Rapamune dosage: . During the same period patient was treated with METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), PREDNISOLONE (25 Mg; Decreased To 2.5 Mg; Increased To 30 Mg) (View Prednisolone Review and Prednisolone Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ).

6753541-6 | Condition Aggravated, Pneumococcal Sepsis, Renal Failure
Patient was taking Rapamune (View Usage). Patient had the following side effects: condition aggravated, pneumococcal sepsis, renal failure on Jun 02, 2010 from GERMANY Additional patient health information: Female patient , 61 years of age, weighting 141.1 lb, was diagnosed with prophylaxis against transplant rejection, hyperuricaemia, hypertension, calcium deficiency and. Rapamune dosage: . During the same period patient was treated with SANDIMMUNE (View Sandimmune Review and Sandimmune Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), CALCIMAGON (View Calcimagon Review and Calcimagon Label ), CYNT (1-2 Tablets Two Times Per Day) (View Cynt Review and Cynt Label ). Patient was hospitalized.

6752399-9 | Eye Prosthesis Insertion, Surgical Procedure Repeated
Adverse event was reported on Jun 01, 2010 by a Female patient taking Rapamune (View Usage) (Dosage: 1.1 Ml Bid Po) was diagnosed with neurofibromatosis (What is neurofibromatosis?) and. Location: UNITED STATES , weighting 52.50 lb, After Rapamune was administered, patient had the following side effects: eye prosthesis insertion, surgical procedure repeated. During the same period patient was treated with AEOROSOLIZED PENTAMIDINE (View Aeorosolized Pentamidine Review and Aeorosolized Pentamidine Label ). Patient was hospitalized.

6739528-8 | Condition Aggravated, Hydronephrosis, Pain, Renal Failure Chronic, Tubulointerstitial Nephritis
on May 18, 2010 Male patient from SWITZERLAND , 68 years of age, was diagnosed with pain (What is pain?) and was treated with Rapamune (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, hydronephrosis, pain (What is pain?), renal failure chronic, tubulointerstitial nephritis. Rapamune dosage: . During the same period patient was treated with NITRODERM (View Nitroderm Review and Nitroderm Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), NOZINAN (View Nozinan Review and Nozinan Label ), MAPROTILINE MESILATE (View Maprotiline Mesilate Review and Maprotiline Mesilate Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), EVEROLIMUS (Possibly Started In Jan-2010) (View Everolimus Review and Everolimus Label ), DIPYRONE TAB (View Dipyrone Tab Review and Dipyrone Tab Label ), NEXIUM (View Nexium Review and Nexium Label ). Patient was hospitalized.

6735253-8 | Ear Disorder, Encephalopathy, Headache, Hypokinesia, Loss Of Consciousness, Photophobia, Psychomotor Retardation, Speech Disorder, Vertigo
on May 18, 2010 Male patient from SWITZERLAND , 19 years of age, was diagnosed with tuberous sclerosis (What is tuberous sclerosis?) and was treated with Rapamune (View Usage). Patient had the following side effects: ear disorder, encephalopathy, headache (What is headache?), hypokinesia, loss of consciousness, photophobia, psychomotor retardation, speech disorder, vertigo. Rapamune dosage: . Patient was hospitalized.

6731723-7 | Abdominal Pain, Ascites, Blood Bilirubin Increased, Cardiac Arrest, Coagulopathy, Epistaxis, Gallbladder Disorder, Gastrointestinal Disorder, Multi-organ Failure
Patient was taking Rapamune (View Usage). After Rapamune was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), ascites, blood bilirubin increased, cardiac arrest (What is cardiac arrest?), coagulopathy, epistaxis, gallbladder disorder, gastrointestinal disorder, multi-organ failure on May 18, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 55.12 lb, . Rapamune dosage: 54.6 Mg. During the same period patient was treated with CYCLOPHOSPHAMIDE (2960 Mg) (View Cyclophosphamide Review and Cyclophosphamide Label ), METHOTREXATE (13.5 Mg) (View Methotrexate Review and Methotrexate Label ), TACROLIMUS (23.6466 Mg) (View Tacrolimus Review and Tacrolimus Label ), THIOTEPA (240 Mg) (View Thiotepa Review and Thiotepa Label ). Patient was hospitalized.

6725659-5 | Abdominal Pain, Diarrhoea, Lung Disorder, Nausea
Adverse event was reported on May 10, 2010 by a Male patient taking Rapamune (View Usage) (Dosage: ) was diagnosed with prophylaxis against transplant rejection and. Location: FRANCE , 62 years of age, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), diarrhoea, lung disorder, nausea (What is nausea?). Patient was hospitalized.

6724303-0 | Disease Progression, Lymphostasis
on May 12, 2010 Male patient from RUSSIAN FEDERATION , 61 years of age, was diagnosed with kaposi's sarcoma (What is kaposi's sarcoma?), prophylaxis against transplant rejection and was treated with Rapamune (View Usage). Patient had the following side effects: disease progression, lymphostasis. Rapamune dosage: . During the same period patient was treated with MYFORTIC (View Myfortic Review and Myfortic Label ). Patient was hospitalized.

6721709-0 | Mycoplasma Infection, Pneumonitis
on May 07, 2010 Female patient from CANADA , child 10 years of age, was diagnosed with renal transplant and was treated with Rapamune (View Usage). After Rapamune was administered, patient had the following side effects: mycoplasma infection, pneumonitis. Rapamune dosage: . Patient was hospitalized.

6720009-2 | Acute Respiratory Distress Syndrome
Patient was taking Rapamune (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory distress syndrome on May 04, 2010 from UNITED STATES Additional patient health information: Female patient , 74 years of age, was diagnosed with prophylaxis against transplant rejection and. Rapamune dosage: Dose And Frequency Not Specified. Patient was hospitalized.

6710466-X | Amyotrophy, Bone Pain, Polyneuropathy, Quadriplegia
Adverse event was reported on Apr 27, 2010 by a Male patient taking Rapamune (View Usage) (Dosage: ) was diagnosed with renal transplant and. Location: GERMANY , 57 years of age, weighting 145.5 lb, Patient had the following side effects: amyotrophy, bone pain, polyneuropathy, quadriplegia.

6680986-5 | Gastrointestinal Stoma Complication
on Apr 06, 2010 Male patient from UNITED STATES , weighting 136.1 lb, was diagnosed with acute graft versus host disease in skin, pain (What is pain?), vomiting, nausea (What is nausea?) and was treated with Rapamune (View Usage). After Rapamune was administered, patient had the following side effects: gastrointestinal stoma complication. Rapamune dosage: . During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), URSODEOXYCHOLIC ACID (View Ursodeoxycholic Acid Review and Ursodeoxycholic Acid Label ), PROTONIX (40 Mg) (View Protonix Review and Protonix Label ), MICAFUNGIN SODIUM (View Micafungin Sodium Review and Micafungin Sodium Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), DILAUDID (1 Via Continous Intravenous Drip And 1 Mg Iv Every 2 Hours As Needed) (View Dilaudid Review and Dilaudid Label ), ZOFRAN (4 Mg Every 6 Hours As Needed) (View Zofran Review and Zofran Label ). Patient was hospitalized.

6678193-5 | Abdominal Distension, Coagulopathy, Dyspnoea, Fatigue, Haemoglobin Decreased, Haemoptysis, Heart Rate Increased, Orthopnoea, Pallor
on Apr 08, 2010 Female patient from UNITED STATES , child 8 years of age, weighting 61.29 lb, was diagnosed with lymphatic disorder and was treated with Rapamune (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, coagulopathy, dyspnoea, fatigue, haemoglobin decreased, haemoptysis, heart rate increased, orthopnoea, pallor. Rapamune dosage: 0.7mg - 1.5mg Bid Po. During the same period patient was treated with SULFAMETHOXAZOLE TIMETHOPRIM (View Sulfamethoxazole-timethoprim Review and Sulfamethoxazole-timethoprim Label ). Patient was hospitalized.

6634243-3 | Cardiac Failure, Lactic Acidosis, Mitral Valve Incompetence, Multi-organ Failure, Pneumonitis, Renal Abscess, Renal Failure, Tachyarrhythmia, Urosepsis
Patient was taking Rapamune (View Usage). Patient had the following side effects: cardiac failure, lactic acidosis, mitral valve incompetence, multi-organ failure, pneumonitis, renal abscess, renal failure, tachyarrhythmia, urosepsis on Mar 04, 2010 from GERMANY Additional patient health information: Female patient , weighting 99.21 lb, was diagnosed with renal transplant and. Rapamune dosage: . During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ), FOLSAN (View Folsan Review and Folsan Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), PROGRAF (View Prograf Review and Prograf Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), VIGANTOLETTEN (View Vigantoletten Review and Vigantoletten Label ). Patient was hospitalized.

6630867-8 | Abdominal Distension, Acute Respiratory Distress Syndrome, Blood Calcium Increased, Bradycardia, Diarrhoea, Haemorrhage, Hepatic Function Abnormal, Hypotension, Metabolic Acidosis
Adverse event was reported on Mar 10, 2010 by a Male patient taking Rapamune (View Usage) (Dosage: 50.4 Mg) . Location: UNITED STATES , weighting 52.47 lb, After Rapamune was administered, patient had the following side effects: abdominal distension, acute respiratory distress syndrome, blood calcium increased, bradycardia, diarrhoea, haemorrhage, hepatic function abnormal, hypotension, metabolic acidosis. During the same period patient was treated with TACROLIMUS (11.79 Mg) (View Tacrolimus Review and Tacrolimus Label ), METHOTREXATE (13.8 Mg) (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

6582290-2 | Chronic Allograft Nephropathy, Oedema Peripheral, Proteinuria, Therapeutic Response Unexpected
on Feb 10, 2010 Male patient from AUSTRALIA , 52 years of age, was treated with Rapamune (View Usage). Patient experienced the following unwanted or unexpected effects: chronic allograft nephropathy, oedema peripheral, proteinuria, therapeutic response unexpected. Rapamune dosage: Had Been On Rapamune For 3 Years.

6580467-3 | Mycoplasma Infection, Pneumonitis
on Feb 09, 2010 Female patient from CANADA , child 10 years of age, was diagnosed with renal transplant and was treated with Rapamune (View Usage). Patient had the following side effects: mycoplasma infection, pneumonitis. Rapamune dosage: . Patient was hospitalized.

6579512-0 | Anaemia, Pneumonia
Patient was taking Rapamune (View Usage). After Rapamune was administered, patient had the following side effects: anaemia, pneumonia (What is pneumonia?) on Feb 02, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 193.3 lb, . Rapamune dosage: .

6575972-X | Cardiac Arrest, Pancreas Transplant Rejection, Respiratory Distress
Adverse event was reported on Feb 02, 2010 by a Male patient taking Rapamune (View Usage) (Dosage: ) was diagnosed with prophylaxis against transplant rejection and. Location: UNITED STATES , weighting 130.5 lb, Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), pancreas transplant rejection, respiratory distress. During the same period patient was treated with ASCORBIC ACID/ERGOCALCIFEROL/FOLIC ACID/NICOTINAMIDE/PANTHENOL/RETINOL (View Ascorbic Acid/ergocalciferol/folic Acid/nicotinamide/panthenol/retinol Review and Ascorbic Acid/ergocalciferol/folic Acid/nicotinamide/panthenol/retinol Label ), LOMOTIL (View Lomotil Review and Lomotil Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), MYFORTIC (View Myfortic Review and Myfortic Label ), THYROGLOBULIN (Dose And Frequency Not Specified) (View Thyroglobulin Review and Thyroglobulin Label ), BACTRIM (View Bactrim Review and Bactrim Label ).

6574238-1 | Condition Aggravated, Skin Cancer, Weight Decreased
on Jan 28, 2010 Male patient from UNITED STATES , weighting 111.1 lb, was diagnosed with lung transplant (What is lung transplant?), hypertension and was treated with Rapamune (View Usage). Patient had the following side effects: condition aggravated, skin cancer (What is skin cancer?), weight decreased. Rapamune dosage: . During the same period patient was treated with PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), ABILIFY (View Abilify Review and Abilify Label ), COZAAR (View Cozaar Review and Cozaar Label ), BACTRIM (View Bactrim Review and Bactrim Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), PROGRAF (View Prograf Review and Prograf Label ), FOSAMAX (View Fosamax Review and Fosamax Label ).

6569168-5 | Liver Function Test Abnormal, Nephropathy Toxic, Renal Failure Acute, Respiratory Failure, Stenotrophomonas Infection, Venoocclusive Disease
on Feb 01, 2010 Male patient from UNITED STATES , weighting 255.7 lb, was treated with Rapamune (View Usage). After Rapamune was administered, patient had the following side effects: liver function test abnormal, nephropathy toxic, renal failure acute, respiratory failure, stenotrophomonas infection, venoocclusive disease. Rapamune dosage: 41 Mg. Patient was hospitalized.

6568654-1 | Alanine Aminotransferase Increased, Blood Cholesterol Increased, Blood Triglycerides Increased, Blood Urea Increased, C-reactive Protein Increased, Diabetes Mellitus, Haematocrit Decreased, Haemoglobin Decreased, High Density Lipoprotein Increased
Patient was taking Rapamune (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, blood cholesterol increased, blood triglycerides increased, blood urea increased, c-reactive protein increased, diabetes mellitus, haematocrit decreased, haemoglobin decreased, high density lipoprotein increased on Jan 27, 2010 from GERMANY Additional patient health information: Male patient , 44 years of age, weighting 193.6 lb, was diagnosed with prophylaxis against transplant rejection, oedema, renal hypertension, partial seizures, hypercholesterolaemia, restless legs syndrome and. Rapamune dosage: . During the same period patient was treated with FURORESE (View Furorese Review and Furorese Label ), MYFORTIC (View Myfortic Review and Myfortic Label ), PREDNISOLON (View Prednisolon Review and Prednisolon Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), KEPPRA (View Keppra Review and Keppra Label ), LOCOL (View Locol Review and Locol Label ), MADOPAR (100 Mg Levodopa + 25 Mg Benserazide Per Day) (View Madopar Review and Madopar Label ). Patient was hospitalized.

6565530-5 | Abdominal Pain, Alveolitis, Bronchitis, Cardiac Failure, Clostridium Difficile Colitis, Escherichia Urinary Tract Infection, Femoral Neck Fracture, Pleural Effusion
Adverse event was reported on Jan 28, 2010 by a Female patient taking Rapamune (View Usage) (Dosage: 0.5 Mg Total Daily) . Location: FRANCE , weighting 105.8 lb, Patient had the following side effects: abdominal pain (What is abdominal pain?), alveolitis, bronchitis (What is bronchitis?), cardiac failure, clostridium difficile colitis, escherichia urinary tract infection, femoral neck fracture, pleural effusion. Patient was hospitalized.

6557930-4 | Calciphylaxis, Cardiac Failure, Myocardial Ischaemia, Proteinuria
on Jan 22, 2010 Female patient from UNITED KINGDOM , weighting 235.2 lb, was treated with Rapamune (View Usage). After Rapamune was administered, patient had the following side effects: calciphylaxis, cardiac failure, myocardial ischaemia, proteinuria. Rapamune dosage: . During the same period patient was treated with ALFACALCIDOL (View Alfacalcidol Review and Alfacalcidol Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), AUGMENTIN (View Augmentin Review and Augmentin Label ), CHLORPHENIRAMINE MALEATE (View Chlorpheniramine Maleate Review and Chlorpheniramine Maleate Label ), DIHYDROCODEINE BITARTRATE INJ (View Dihydrocodeine Bitartrate Inj Review and Dihydrocodeine Bitartrate Inj Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ).

6545512-X | Cholestasis, Disease Recurrence, Hiv Infection, Hyperlipidaemia, Hypertension, Myopathy, Renal Impairment
on Jan 18, 2010 Male patient from UNITED KINGDOM , child 9 years of age, was diagnosed with prophylaxis against transplant rejection and was treated with Rapamune (View Usage). Patient experienced the following unwanted or unexpected effects: cholestasis, disease recurrence, hiv infection (What is hiv infection?), hyperlipidaemia, hypertension, myopathy, renal impairment. Rapamune dosage: . During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), SUSTIVA (View Sustiva Review and Sustiva Label ), CO TRIMOXAZOLE (Not Provided) (View Co-trimoxazole Review and Co-trimoxazole Label ), DIDANOSINE (Not Provided) (View Didanosine Review and Didanosine Label ), KIVEXA (View Kivexa Review and Kivexa Label ), NELFINAVIR MESYLATE (Not Provided) (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ). Patient was hospitalized.

6545512-X | Cholestasis, Disease Recurrence, Hiv Infection, Hyperlipidaemia, Hypertension, Myopathy, Renal Impairment
Patient was taking Rapamune (View Usage). Patient had the following side effects: cholestasis, disease recurrence, hiv infection (What is hiv infection?), hyperlipidaemia, hypertension, myopathy, renal impairment on Jan 18, 2010 from UNITED KINGDOM Additional patient health information: Male patient , child 9 years of age, was diagnosed with prophylaxis against transplant rejection and. Rapamune dosage: . During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), SUSTIVA (View Sustiva Review and Sustiva Label ), COTRIM (Not Provided) (View Cotrim Review and Cotrim Label ), DIDANOSINE (Not Provided) (View Didanosine Review and Didanosine Label ), ABACAVIR SULFATE AND LAMIVUDINE (View Abacavir Sulfate And Lamivudine Review and Abacavir Sulfate And Lamivudine Label ), NELFINAVIR MESYLATE (Not Provided) (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ). Patient was hospitalized.